These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 12133653

  • 1. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study.
    Lancet; 2002 Jul 20; 360(9328):196-202. PubMed ID: 12133653
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr 20; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 20; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 4. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G.
    Eur J Heart Fail; 2003 Jan 20; 5(1):101-8. PubMed ID: 12559222
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007 Jan 20; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 6. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
    Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, Ginesta V, Rubio J, García-Bengoechea JB, González-Juanatey JR.
    Rev Esp Cardiol; 2006 Apr 20; 59(4):338-45. PubMed ID: 16709386
    [Abstract] [Full Text] [Related]

  • 7. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G.
    Eur J Heart Fail; 2010 Apr 20; 12(4):404-10. PubMed ID: 20335355
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L, Cui L, Wei JP, Li GP, Qi GX, Hao YM, Wang WZ, Li HM, Liu J, Jiang DJ, Zhang YD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun 20; 38(6):527-30. PubMed ID: 21033135
    [Abstract] [Full Text] [Related]

  • 9. Levosimendan: a review of its use in the management of acute decompensated heart failure.
    Innes CA, Wagstaff AJ.
    Drugs; 2003 Jun 20; 63(23):2651-71. PubMed ID: 14636085
    [Abstract] [Full Text] [Related]

  • 10. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S.
    Cochrane Database Syst Rev; 2018 Jan 29; 1(1):CD009669. PubMed ID: 29376560
    [Abstract] [Full Text] [Related]

  • 11. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH, LEVO-CTS Investigators.
    N Engl J Med; 2017 May 25; 376(21):2032-2042. PubMed ID: 28316276
    [Abstract] [Full Text] [Related]

  • 12. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J, Taboada M, Rodríguez J, Caruezo V, Bouzada M, Campaña O, Bascuas B, Pérez-Paz J, Ginesta V.
    Rev Esp Anestesiol Reanim; 2005 May 25; 52(7):389-94. PubMed ID: 16200918
    [Abstract] [Full Text] [Related]

  • 13. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y.
    Expert Opin Pharmacother; 2007 Apr 25; 8(5):665-77. PubMed ID: 17376021
    [Abstract] [Full Text] [Related]

  • 14. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S, Rakić S, Nikolić L, Jovicić B, Stajević M, Vukomanović V, Kosutić J.
    Vojnosanit Pregl; 2011 Nov 25; 68(11):979-84. PubMed ID: 22191317
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B.
    Int J Clin Pharmacol Ther; 2004 Apr 25; 42(4):204-11. PubMed ID: 15124978
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
    Moiseyev VS, Põder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI, RUSSLAN Study Investigators.
    Eur Heart J; 2002 Sep 25; 23(18):1422-32. PubMed ID: 12208222
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
    Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M, SURVIVE Investigators.
    JAMA; 2007 May 02; 297(17):1883-91. PubMed ID: 17473298
    [Abstract] [Full Text] [Related]

  • 18. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
    Antila S, Eha J, Heinpalu M, Lehtonen L, Loogna I, Mesikepp A, Planken U, Sandell EP.
    Eur J Clin Pharmacol; 1996 May 02; 49(6):451-8. PubMed ID: 8706769
    [Abstract] [Full Text] [Related]

  • 19. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
    Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, Tanus E, del Mazo CD.
    Rev Esp Cardiol; 2008 May 02; 61(5):471-9. PubMed ID: 18462650
    [Abstract] [Full Text] [Related]

  • 20. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabrò MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group.
    N Engl J Med; 2017 May 25; 376(21):2021-2031. PubMed ID: 28320259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.